Alexis Baass

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications

Validation of two familial chylomicronemia syndrome clinical diagnosis scores in a cohort of molecularly defined patients.

Validation of two familial chylomicronemia syndrome clinical diagnosis scores in a cohort of molecularly defined patients.

Journal: Journal of clinical lipidology
Published: April 24, 2026

Homozygous familial hypercholesterolemia (HoFH) in Canada.

Homozygous familial hypercholesterolemia (HoFH) in Canada.

Journal: Atherosclerosis
Published: March 20, 2026

Polygenic risk scores in familial hypercholesterolemia. Do they have a role?

Polygenic risk scores in familial hypercholesterolemia. Do they have a role?

Journal: Current opinion in lipidology
Published: February 28, 2026

Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR Trials.

Use of plozasiran across a spectrum of hypertriglyceridemia: Long-term efficacy and safety data from the open-label extension period of SHASTA-2 and MUIR Trials.

Journal: American journal of preventive cardiology
Published: February 16, 2026

Novel MFN2 compound heterozygote genotype in a patient with multiple symmetric lipomatosis and metabolic dysfunction.

Novel MFN2 compound heterozygote genotype in a patient with multiple symmetric lipomatosis and metabolic dysfunction.

Journal: Journal of clinical lipidology
Published: December 05, 2025

Poor Performance of LDL-Cholesterol Equations versus Beta Quantification in a Very Large Cohort of Patients with Dyslipidemia.

Poor Performance of LDL-Cholesterol Equations versus Beta Quantification in a Very Large Cohort of Patients with Dyslipidemia.

Journal: Clinical chemistry
Published: November 17, 2025

Aortic Stenosis in Homozygous Familial Hypercholesterolemia: The Canadian HoFH Registry.

Aortic Stenosis in Homozygous Familial Hypercholesterolemia: The Canadian HoFH Registry.

Journal: JACC. Advances
Published: August 14, 2025

Integration of a polygenic score into clinical risk prediction of atherosclerotic cardiovascular disease in familial hypercholesterolemia.

Integration of a polygenic score into clinical risk prediction of atherosclerotic cardiovascular disease in familial hypercholesterolemia.

Journal: European journal of preventive cardiology
Published: August 08, 2025

Extreme lipoprotein(a) is a cardiovascular risk equivalent in heterozygous familial hypercholesterolemia.

Extreme lipoprotein(a) is a cardiovascular risk equivalent in heterozygous familial hypercholesterolemia.

Journal: Journal of clinical lipidology
Published: June 04, 2025

DNA methylation levels are independently associated with prevalence of atherosclerotic cardiovascular disease in multifactorial chylomicronemia syndrome.

DNA methylation levels are independently associated with prevalence of atherosclerotic cardiovascular disease in multifactorial chylomicronemia syndrome.

Journal: Clinical biochemistry
Published: April 29, 2025

Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participants.

Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participants.

Journal: Journal of clinical lipidology
Published: January 16, 2025

Lp(a): A Clinical Review.

Lp(a): A Clinical Review.

Journal: Clinical biochemistry
Published: January 06, 2025
Showing 1-12 of 105

Last Updated: 09/26/2026